Unknown

Dataset Information

0

Piezo1 activation using Yoda1 inhibits macropinocytosis in A431 human epidermoid carcinoma cells.


ABSTRACT: Macropinocytosis is a type of endocytosis accompanied by actin rearrangement-driven membrane deformation, such as lamellipodia formation and membrane ruffling, followed by the formation of large vesicles, macropinosomes. Ras-transformed cancer cells efficiently acquire exogenous amino acids for their survival through macropinocytosis. Thus, inhibition of macropinocytosis is a promising strategy for cancer therapy. To date, few specific agents that inhibit macropinocytosis have been developed. Here, focusing on the mechanosensitive ion channel Piezo1, we found that Yoda1, a Piezo1 agonist, potently inhibits macropinocytosis induced by epidermal growth factor (EGF). The inhibition of ruffle formation by Yoda1 was dependent on the extracellular Ca2+ influx through Piezo1 and on the activation of the calcium-activated potassium channel KCa3.1. This suggests that Ca2+ ions can regulate EGF-stimulated macropinocytosis. We propose the potential for macropinocytosis inhibition through the regulation of a mechanosensitive channel activity using chemical tools.

SUBMITTER: Kuriyama M 

PROVIDER: S-EPMC9012786 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Piezo1 activation using Yoda1 inhibits macropinocytosis in A431 human epidermoid carcinoma cells.

Kuriyama Masashi M   Hirose Hisaaki H   Masuda Toshihiro T   Shudou Masachika M   Arafiles Jan Vincent V JVV   Imanishi Miki M   Maekawa Masashi M   Hara Yuji Y   Futaki Shiroh S  

Scientific reports 20220415 1


Macropinocytosis is a type of endocytosis accompanied by actin rearrangement-driven membrane deformation, such as lamellipodia formation and membrane ruffling, followed by the formation of large vesicles, macropinosomes. Ras-transformed cancer cells efficiently acquire exogenous amino acids for their survival through macropinocytosis. Thus, inhibition of macropinocytosis is a promising strategy for cancer therapy. To date, few specific agents that inhibit macropinocytosis have been developed. He  ...[more]

Similar Datasets

| S-EPMC5913400 | biostudies-literature
| S-EPMC7261832 | biostudies-literature
| S-EPMC3725735 | biostudies-literature
| S-EPMC8622727 | biostudies-literature
2013-06-18 | GSE47996 | GEO
| S-EPMC5835220 | biostudies-literature
2013-06-18 | E-GEOD-47996 | biostudies-arrayexpress
| S-EPMC4223496 | biostudies-literature
| S-EPMC6063857 | biostudies-literature
| S-EPMC9016416 | biostudies-literature